Jounce Therapeutics Inc logo

Jounce Therapeutics Inc Share Price Today (NASDAQ: JNCE)

Jounce Therapeutics Inc share price is $0 & ₹0.00 as on 2 May 2023 IST

▲

-1.88

(-100%)

Market is closed - opens 7 PM, 02 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 3 May 2023

View live Jounce Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Jounce Therapeutics Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Jounce Therapeutics Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Jounce Therapeutics Inc (JNCE) Key Statistics

in dollars & INR

Previous Close
$1.88
Open
$1.92
Market Capitalization
$100.5M
Today's Volume
$11.6M
Revenue TTM
$82.0M
EBITDA
$-50.2M
Earnings Per Share (EPS)
$-0.98
Dividend Yield
0.0%
Profit Margin
-62.1%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-25.03%

How to invest in Jounce Therapeutics Inc Stock (JNCE) from India?

It is very easy for Indian residents to invest directly in Jounce Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Jounce Therapeutics Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Jounce Therapeutics Inc or JNCE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Jounce Therapeutics Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Jounce Therapeutics Inc shares which would translate to null fractional shares of Jounce Therapeutics Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Jounce Therapeutics Inc, in just a few clicks!

Global Institutional Holdings in Jounce Therapeutics Inc

  • RTW INVESTMENTS, LLC

    9.75%

  • Deep Track Capital, LP

    8.14%

  • COWEN AND COMPANY, LLC

    6.97%

  • Bank of America Corp

    6.26%

  • BlackRock Inc

    4.91%

  • Millennium Management LLC

    3.49%

Analyst Recommendation on Jounce Therapeutics Inc

Rating
Trend

Buy

    76%Buy

    23%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Jounce Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Jounce Therapeutics Inc

Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. It develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. The company is also developing JTX-8064, a monoclonal antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; and Pimivalimab, an anti-PD-1 antibody for combination therapy. In addition, its preclinical products are JTX-1484, a monoclonal antibody designed to reduce myeloid-mediated immune suppression; and JTX-2134, a monoclonal antibody designed to reduce myeloid-mediated immune suppression and activate T and NK cells. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts.
Organization
Jounce Therapeutics Inc
Employees
141
CEO
Dr. Richard Murray Ph.D.
Industry
Health Technology

Important FAQs about investing in JNCE Stock from India :

Can Indians buy Jounce Therapeutics Inc shares?

Yes, Indians can invest in the Jounce Therapeutics Inc (JNCE) from India.

With INDmoney, you can buy Jounce Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Jounce Therapeutics Inc at zero transaction cost.

How can I buy Jounce Therapeutics Inc shares from India?

It is very easy to buy Jounce Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Jounce Therapeutics Inc (JNCE) be purchased?

Yes, you can buy fractional shares of Jounce Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Jounce Therapeutics Inc stocks?

To start investing in Jounce Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Jounce Therapeutics Inc?

Today's market capitalisation of Jounce Therapeutics Inc JNCE is 100.5M

Who is the Chief Executive Officer (CEO) of Jounce Therapeutics Inc ?

Dr. Richard Murray Ph.D. is the current Chief Executive Officer (CEO) of Jounce Therapeutics Inc.